Biomarkers Market Size, Industry Share, Top Manufacturers, Demand and Forecast to 2023
Explore Sample Copy of this Research Report: https://www.psmarketresearch.com/market-analysis/biomarkers-market/report-sample
Factors such as rising demand of personalized medicine, and companion diagnostics are some of the major growth drivers for the global biomarker market. Recent advancements in the discovery technologies such as genome sequencing are also contributing to the overall growth of the global biomarker market. Increasing personalized solution for cancer treatment, and prevention, rising interdisciplinary systems biology approach and development of OMICS technology is expected to drive the market during the forecast period.
North America was the largest market of biomarkers in 2014. The market dominance of North America is attributed to the high concentration of pharmaceutical company and their research and development (R&D) center in this region, also the aging population and rising healthcare expenditure in North America is fueling the demand of biomarker in this region. Asia-Pacific market is estimated to be fasted growing market of biomarkers in coming years, attributed to the rising healthcare infrastructure and rising healthcare awareness among the consumers in developing countries. Country wise the U.S. and Canada are some of the major market of biomarkers in North America. Italy, Germany, Spain, the U.K., and France are some of the dominant biomarker market in Europe. China, India, and Japan are major biomarker market in Asia-Pacific.
Explore Report at: https://www.psmarketresearch.com/market-analysis/biomarkers-market
Some of the major players operating in the global biomarkers market include, Abbott Laboratories, Affymetrix Inc., Agilent Technologies Inc., Dickinson and Company, Becton, Celera Corporation., Epigenomics AG., Bruker Corporation, DiagnoCure Inc., GE Healthcare, Siemens AG, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Clarient Inc., hermo Fisher Scientific, Inc., Epistem Ltd., and Aushon BioSystem Inc.
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biomarkers Market Size, Industry Share, Top Manufacturers, Demand and Forecast to 2023 here
News-ID: 1003357 • Views: 141
More Releases from P&S Market Research - Biotechnology
Molecular Cytogenetics Market is Expected to Witness Fastest Growth in Personali …
Global molecular cytogenetics market is forecasted to attain revenue of $3.3 billion by 2023. The market is mainly driven by growing implementation of pharmacogenomics in personalized disease management and drug development, rising cancer cases, advancements in cytogenetic techniques, and rise in genetic-based prediction of chromosomal abnormalities. Request for Sample Copy of this Research Report at: https://www.psmarketresearch.com/market-analysis/molecular-cytogenetics-market/report-sample Based on offering, the molecular cytogenetics market has been categorized into consumables, software and services and
Centrifugation Technique is Expected to Continue Generating the Largest Revenue …
Global cell isolation market size is expected to reach $12.6 billion by 2023. The market is mainly driven by rising demand for biopharmaceuticals, increasing government funding for cell-based research, and growing research on personalized medicine. Request for Sample Copy of this Research Report at: https://www.psmarketresearch.com/market-analysis/cell-isolation-market/report-sample Based on product, the cell isolation market is categorized into consumables and instruments. Consumables generated revenue of more than $2.5 billion, accounting for 61.4% share, in the
DNA Sequencing Market by Product, Technology, Application, End User and Geograph …
The global DNA Sequencing market size is projected to achieve a lucrative growth based on the advent of technological innovations and extensive clinical applications. The market is expected to be led by consumable products, in terms of both size and growth during the forecast period (2018-2023). This is attributed to the extensive use of consumables for sample preparation, cluster generation, and other processes during the course of experiments. Request to
Metabolomics Market - Popular Trends & Technological advancements to Watch Out f …
The global metabolomics market is projected to achieve a lucrative growth rate during the forecast period due to the increased government and private funding in research and development, and rise in metabolic application in personalized medication. Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/metabolomics-market North America is the largest market for metabolomics products and services, mainly due to the factors such as presence of large number of funding from government and private
More Releases for Biomarkers
Biomarkers Market Fragmented by 2025
Global Biomarkers Market: Snapshot The global biomarkers market is witnessing a tremendous rise in its valuation, thanks to the increase in diagnostic applications of biomarkers. The augmenting investments for research and development activities in the pharma and biotech companies, rising number of CROs, and the low cost associated with the clinical trials in emerging economies are also boosting this market. Going forward, the high prevalence rate of cancer and novel initiatives for
Cancer Biomarkers Market: Regional Overview
Cancer is the second-leading cause of death worldwide (World Health Organization). There were around 14 million new cases of cancer reported across the globe in 2012 and the incidence rate is expected to increase by around 70% by 2030 (WHO). The most common cancer types are lung cancer, liver cancer, colorectal cancer, stomach cancer, and breast cancer. Cancer therapies are expensive and the cost rises with increase in complexity or stage
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Biomarkers Market : Analysis & Trends 2023
Global Biomarkers Market A biomarker refers to a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures, and biological procedures. Also known as a molecular marker or signature molecule, biomarkers are found in blood, other body fluids, and tissue. Extensively used to see the body’s response to a particular treatment for a disease or condition, biomarkers assist medical professionals to take effective clinical decisions
Global Vocal Biomarkers Market
The Global Vocal Biomarkers Market is estimated to be valued at US$ 6.4 million by 2017 and is projected to expand at an astounding CAGR of 65.7% from 2017 to 2028, as analyzed by Coherent Market Insights. Vocal biomarkers enabling early diagnosis and being a non-invasive procedure are analyzed to be major factor fueling uptake of this disruptive technology over the forecast period (2017–2028). Mental and physical conditions such as anxiety
SMi present their 4th annual conference on Biomarkers Summit Monday 31st January & Tuesday 1st February 2011 Crowne Plaza The-City, London, UK Don’t Miss Out - Visit to register your place today http://www.smi-online.co.uk/preclinical-biomarkers.asp Sponsored by Caprotec Cell Signalling Technology GVK Bio Selventa Millipore Quest Diagnostics RBM SMi’s highly anticipated 4th annual Biomarkers Summit is fast approaching, and time is running out